Skip to content

Clinical application of remifentanil in pediatric anesthesia

Clinical application of remifentanil in pediatric anesthesia

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093817
Enrollment
Unknown
Registered
2024-12-12
Start date
2024-11-04
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Separation anxiety

Interventions

Experimental group:The first patient received intravenous injection of remifentanil at a dose of 0.1mg/kg, and the next dose of remifentanil was determined based on the child's PSAS score. If the scor

Sponsors

Fuyang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 6 Years

Inclusion criteria

Inclusion criteria: (1) ASA Level I-II; (2) Preoperative PSAS score >= 3 points; (3) Age 1-6 years old; (4) Surgical time <= 1 hour; (5) After explaining the content of the clinical trial, the guardian voluntarily joined and signed informed consent.

Exclusion criteria

Exclusion criteria: (1) History of neurological disorders, mental illnesses, and cardiovascular diseases; (2) History of anesthesia surgery; (3) Children who are allergic to the drugs used in the study; (4) Patients who use sedatives or analgesics 24 hours before surgery;

Design outcomes

Primary

MeasureTime frame
PSAS for children separated from their parents;

Secondary

MeasureTime frame
Sedation score for children separated from their parents;MAP, HR, SpO2;Anesthesia awakening time;Agitation Scale for Anesthesia Recovery Period;

Countries

China

Contacts

Public ContactWu Meichao

Fuyang People's Hospital

ksly0501@163.com+86 181 1053 1585

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026